Project Grant H8G48668

FEDERAL COOPERATIVE AGREEMENT SUMMARY The New York City Department of Health and Mental Hygiene's Bureau of Immunization received a $10.3 million Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) to strengthen vaccine-preventable disease prevention and response efforts across New York City's population of 8.3 million residents. The five-year award, effective July 1, 2025 through June 30,...

Federal Cooperative Agreement Award Summary The Florida Department of Health received a $20.74M Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award, effective July 1, 2025, through June 30, 2030, supports Florida's efforts to strengthen vaccine-preventable disease (VPD) prevention and response capabilities across the...

Federal Cooperative Agreement Summary The Virginia Department of Health (VDH) received a $5.39 million Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283), effective July 1, 2025, through June 30, 2030. This award funds the Strengthening Vaccine-Preventable Disease Prevention and Response Initiative, which delivers integrated immunization services and disease prevention infrastructure across...

The Centers for Disease Control and Prevention (CDC), through its Investigations and Technical Assistance program (CFDA 93.283), awarded a cooperative agreement of $378,547 to the Palau Ministry of Health, effective July 1, 2025, through June 30, 2030. This award supports the strengthening of vaccine-preventable disease (VPD) prevention and response capabilities across the Republic of Palau, a geographically dispersed island nation with a population of approximately 17,614 residents. The...

Federal Cooperative Agreement Summary The Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases awarded $1,136,100 to the Virgin Islands Department of Health through a five-year Cooperative Agreement (Award Date: July 1, 2025; Completion Date: June 30, 2030) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award supports strengthening vaccine-preventable disease prevention and response through the U.S. Virgin...

Summary: Strengthening Vaccine-Preventable Disease Prevention and Response in Puerto Rico The Puerto Rico Department of Health received a $1,549,214 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268), effective July 1, 2025 through June 30, 2030. This five-year award supports enhanced immunization program management and vaccine-preventable disease prevention across Puerto Rico, addressing critical...

Federal Cooperative Agreement Summary The Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases awarded a $3.02 million Cooperative Agreement (CFDA 93.268, Immunization Cooperative Agreements) to the Vermont Agency of Human Services on July 1, 2025, for a five-year performance period through June 30, 2030. This award supports the Vermont Department of Health Immunization Program's core mission to strengthen vaccine-preventable disease (VPD)...

Federal Cooperative Agreement Summary The District of Columbia Department of Health (DC Health) received a $5.34 million Cooperative Agreement from the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award, effective July 1, 2025 through June 30, 2030, supports DC Health's Community Health Administration Immunization Division in implementing a comprehensive...

Federal Cooperative Agreement Summary The State of Alaska Department of Health received a $2,543,571 Cooperative Agreement, effective July 1, 2025 through June 30, 2030, from the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases under the Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases program (CFDA 93.083). The award supports Alaska's immunization program in strengthening...

Federal Cooperative Agreement Summary The Centers for Disease Control and Prevention (CDC), through its National Center for Immunization and Respiratory Diseases, awarded a $45.2 million Cooperative Agreement to the Texas Department of State Health Services (DSHS) Infectious Disease Prevention Division, Immunizations Section, effective July 1, 2025 through June 30, 2030. This collaborative award supports the Strengthening Vaccine-Preventable Disease Prevention and Response initiative, which...